Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE studyEfstathios Kastritis,Evangelos Terpos,Argiris Symeonidis,Vasiliki Labropoulou,Sosana Delimpasi,Katia Mancuso,Elena Zamagni,Eirini Katodritou,Elena Rivolti,Marie-Christine Kyrtsonis,Maria Roussou,Despina Fotiou,Foteini Theodorakakou,Ioannis Ntanasis-Stathopoulos,Evdoxia Hatjiharissi,Nikolaos Kanellias,Magdalini Migkou,Giorgos Cheliotis,Kyriaki Manousou,Maria Gavriatopoulou,Meletios A. DimopoulosAmerican journal of hematology(2023)引用 2|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要